Impact of Percutaneous Cryoablation on Renal Function in Patients with Stage I Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
David-Dimitris ChlorogiannisAnargyros ChlorogiannisDimitrios K FilippiadisAlexis KelekisGregory C MakrisChristos GeorgiadesPublished in: Journal of vascular and interventional radiology : JVIR (2024)
Percutaneous cryoablation for Stage 1 renal cell carcinoma has minimal significant impact on renal function (measured by eGFR or serum creatinine). The same outcome was observed in patients with larger tumors (T1b) and those with solitary kidneys.